Searchable abstracts of presentations at key conferences in endocrinology

ea0032p1114 | Thyroid cancer | ECE2013

Prevalence of hypovitaminosis D in patients with papillary thyroid carcinoma (PTC)

Kowalska Aldona , Gasior-Perczak Danuta , Palyga Iwona , Siolek Monika , Sluszniak Anna , Mezyk Ryszard , Gozdz Stanislaw

Introduction: The correct 25-hydroxy vitamin D (25(OH)D) level plays a key role in the proper supply of vitamin D for the organism. Vitamin D deficiency may lead to an increased risk of development of various neoplasms, including papillary thyroid carcinoma (PTC).Aim: Evaluation of the prevalence of vitamin D deficiency in patients with PTC and analysis of the relation between 25(OH)D levels and age, sex, place of living, severity of the disease, and pre...

ea0035p1144 | Thyroid Cancer | ECE2014

Coexistence of mutations in the CHEK2 and BRAFV600E genes and their impact on the course of the papillary thyroid carcinoma (PTC)

Gasior-Perczak Danuta , Kowalska Aldona , Palyga Iwona , Walczyk Agnieszka , Siolek Monika , Kowalik Artur , Mezyk Ryszard , Gozdz Stanislaw

Introduction: The activating BRAFV600E is the most common genetic alteration in PTC. There is a common belief that it can correlate with a more aggressive clinical course. The mutation of the CHEK2 gene impairs the repair processes of the damaged DNA. It can be expected that the coexistence of both mutations can be related to a worse clinical course.Aim: To assess the prevalence of the coexistence of the CHEK2 and BRAFV600E mutation...